Selected research
Industry Research
Opicapone Capsules Industry Research Report 2026
Market perspective
The global Opicapone Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Opicapone Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Opicapone Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Opicapone Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Opicapone Capsules include Amneal, Ono Pharmaceutica and Fosun Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Opicapone Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Opicapone Capsules Market by Company
Amneal
Ono Pharmaceutica
Fosun Pharma
Opicapone Capsules Segment by Type
25mg per Unit
50mg per Unit
Opicapone Capsules Segment by Application
Hospital and Clinic
Pharmacy
Other
Opicapone Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opicapone Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Opicapone Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opicapone Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Opicapone Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Opicapone Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Opicapone Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 25mg per Unit
- 50mg per Unit
Applications
- Hospital and Clinic
- Pharmacy
- Other
Companies covered
- Amneal
- Ono Pharmaceutica
- Fosun Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Opicapone Capsules Market Size (2021-2032)
- 2.2.2 Global Opicapone Capsules Sales (2021-2032)
- 2.2.3 Global Opicapone Capsules Market Average Price (2021-2032)
- 2.3 Opicapone Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 25mg per Unit
- 2.3.3 50mg per Unit
- 2.4 Opicapone Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital and Clinic
- 2.4.3 Pharmacy
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Opicapone Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Opicapone Capsules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Opicapone Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Opicapone Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Opicapone Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Opicapone Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Opicapone Capsules, Product Type & Application
- 3.8 Global Manufacturers of Opicapone Capsules, Established Date
- 3.9 Global Opicapone Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Amneal
- 4.1.1 Amneal Company Information
- 4.1.2 Amneal Business Overview
- 4.1.3 Amneal Opicapone Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Amneal Opicapone Capsules Product Portfolio
- 4.1.5 Amneal Recent Developments
- 4.2 Ono Pharmaceutica
- 4.2.1 Ono Pharmaceutica Company Information
- 4.2.2 Ono Pharmaceutica Business Overview
- 4.2.3 Ono Pharmaceutica Opicapone Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Ono Pharmaceutica Opicapone Capsules Product Portfolio
- 4.2.5 Ono Pharmaceutica Recent Developments
- 4.3 Fosun Pharma
- 4.3.1 Fosun Pharma Company Information
- 4.3.2 Fosun Pharma Business Overview
- 4.3.3 Fosun Pharma Opicapone Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Fosun Pharma Opicapone Capsules Product Portfolio
- 4.3.5 Fosun Pharma Recent Developments
5 Global Opicapone Capsules Market Scenario by Region
- 5.1 Global Opicapone Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Opicapone Capsules Sales by Region: 2021-2032
- 5.2.1 Global Opicapone Capsules Sales by Region: 2021-2026
- 5.2.2 Global Opicapone Capsules Sales by Region: 2027-2032
- 5.3 Global Opicapone Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Opicapone Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Opicapone Capsules Revenue by Region: 2027-2032
- 5.4 North America Opicapone Capsules Market Facts & Figures by Country
- 5.4.1 North America Opicapone Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Opicapone Capsules Sales by Country (2021-2032)
- 5.4.3 North America Opicapone Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Opicapone Capsules Market Facts & Figures by Country
- 5.5.1 Europe Opicapone Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Opicapone Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Opicapone Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Opicapone Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Opicapone Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Opicapone Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Opicapone Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Opicapone Capsules Market Facts & Figures by Country
- 5.7.1 South America Opicapone Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Opicapone Capsules Sales by Country (2021-2032)
- 5.7.3 South America Opicapone Capsules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Opicapone Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Opicapone Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Opicapone Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Opicapone Capsules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Opicapone Capsules Sales by Type (2021-2032)
- 6.1.1 Global Opicapone Capsules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Opicapone Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Opicapone Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Opicapone Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Opicapone Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Opicapone Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Opicapone Capsules Sales by Application (2021-2032)
- 7.1.1 Global Opicapone Capsules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Opicapone Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Opicapone Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Opicapone Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Opicapone Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Opicapone Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Opicapone Capsules Value Chain Analysis
- 8.1.1 Opicapone Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Opicapone Capsules Production Mode & Process
- 8.2 Opicapone Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Opicapone Capsules Distributors
- 8.2.3 Opicapone Capsules Customers
9 Global Opicapone Capsules Analyzing Market Dynamics
- 9.1 Opicapone Capsules Industry Trends
- 9.2 Opicapone Capsules Industry Drivers
- 9.3 Opicapone Capsules Industry Opportunities and Challenges
- 9.4 Opicapone Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst